loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 21988 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE (1)

filter

01 STRIDES ACROLAB (1)

filter

01 TABLET; ORAL (1)

filter

01 150MG; 300MG; 200MG (1)

filter

01 USA (1)

TABLET; ORAL
150MG; 300MG; 200MG
Lamivudine/Zidovudine ...
USA
21988

Looking for CTD TGA MCC DOSSIER APPLICATION 21988

Looking for CTD TGA MCC DOSSIER APPLICATION 21988 1

19

Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

One of their notable products is LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE, with a corresponding application number 21988 and regulatory information .

proudly manufactured in the

Strides Pharma Science's Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets TABLET; ORAL, medication with 150MG; 300MG; 200MG of LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE.

Post Enquiry
POST ENQUIRY